Ascorutin

Contraindications

Hypersensitivity to the components of the drug.

Pharmaceutical form

Tablets of light greenish-yellow color with slight inclusions.

Undesirable effects

Ascorutin is well tolerated, in rare cases, allergic reactions to the components of the drug are possible.

Therapeutic indications

prevention and treatment of hypo-and avitaminosis P and C,

in the complex therapy of diseases accompanied by impaired vascular permeability, including hemorrhagic diathesis, retinal hemorrhages,

prevention and treatment of capillary lesions associated with the use of anticoagulants and salicylates.

Pharmacotherapeutic group

  • Vitamins and vitamin-like products in combinations

Pharmacodynamic properties

Rutin together with ascorbic acid is involved in redox processes. Rutin, due to its antioxidant properties, protects ascorbic acid from excessive oxidation, while maintaining its biological activity. In addition, rutin in combination with ascorbic acid reduces the permeability and fragility of capillaries.

Special precautions for storage

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life of the drug Askorutin3 года.

Do not use after the expiration date indicated on the package.

Instructions for medical use

Askorutin
Instructions for medical use-RU no. R N001034/01

Last modified date: 15.06.2017

Dosage form

Pills.

Composition

The composition of one tablet:

Active ingredients:

Ascorbic acid-50 mg, rutoside (rutin) - 50 mg.

Excipients:

Sucrose – sugar) - 147.1 mg, potato starch-76.2 mg, calcium stearate monohydrate (calcium stearate 1-water) - 2.6 mg, talc-4.1 mg.

Description of the dosage form

Tablets are round, flat-cylindrical in shape, with a chamfer and a risk, light greenish-yellow in color with small inclusions of green, brown and white.

Pharmacological Group

Vitamin.

Pharmacodynamics

Pharmacological action.
Ascorbic acid is involved in the regulation of redox reactions, carbohydrate metabolism, and collagen synthesis.

Rutin eliminates the increased permeability of the capillaries, strengthens the vascular wall.

Indications

Prevention and treatment of hypo-and beriberi C and R.

As part of complex therapy for varicose veins, trophic disorders and skin ulcers, chronic venous insufficiency, hemorrhagic diathesis.

Contraindications

Hypersensitivity, childhood, sucrose/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption.

With caution

Conditions accompanied by hypercoagulation of the blood and a tendency to thrombosis, thrombophlebitis.

Use during pregnancy and lactation

Due to the content of rutin in the drug, it should not be used in the first trimester of pregnancy.

The minimum daily requirement for ascorbic acid in the second-third trimesters of pregnancy is about 60 mg. It should be borne in mind that the fetus can adapt to high doses of ascorbic acid, which is taken by a pregnant woman, and then the newborn may develop a "withdrawal"syndrome.

The minimum daily requirement during lactation is 80 mg. A mother's diet containing an adequate amount of ascorbic acid is sufficient to prevent its deficiency in an infant. Theoretically, there is a danger to the child when the mother uses high doses of ascorbic acid (it is recommended that the nursing mother does not exceed the daily need for ascorbic acid).

When using the drug, it is necessary to observe the dosage and duration of the course of administration prescribed by the doctor during pregnancy and lactation.

Method of administration and dosage

Inside, 1 tablet 2-3 times a day during or after meals. The course of treatment is 2-3 weeks. For prevention - 1-2 tablets per day. The course is determined individually.

Side effects

Allergic reactions, dyspeptic disorders, headache.

Interaction

Ascorbic acid increases the absorption of drugs of the penicillin group, iron, reduces the clinical effect of heparin and indirect anticoagulants.

Release form

Tablets 50 mg 50 mg.

10 tablets in a contour cell package made of polyvinyl chloride film and aluminum foil.

50 tablets in a jar made of polymer material.

Each can of polymer material or 5 contour cell packages, together with the instructions for medical use, is placed in a pack of cardboard for consumer packaging.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Expiration date

3 years. Do not use after the expiration date.

Conditions of supply of pharmacies

They are released without a prescription.

Аскорутин - инструкция по медицинскому применению - РУ № Р N002808/01-2003 от 2008-09-11
Аскорутин - инструкция по медицинскому применению - РУ № Р N001034/01 от 2011-09-19
Аскорутин - инструкция по медицинскому применению - РУ № ЛСР-006693/10 от 2010-07-15
Аскорутин - инструкция по медицинскому применению - РУ № Р N000705/01 от 2011-11-07
Аскорутин - инструкция по медицинскому применению - РУ № Р N001700/01 от 2008-09-12
Аскорутин - инструкция по медицинскому применению - РУ № Р N001034/01 от 2005-11-11
Аскорутин - инструкция по медицинскому применению - РУ № ЛСР-006620/08 от 2008-08-14
Аскорутин - инструкция по медицинскому применению - РУ № Р N000705/01 от 2006-12-29
Аскорутин - инструкция по медицинскому применению - РУ № Р N001680/01 от 2008-04-30
Аскорутин - инструкция по медицинскому применению - РУ № Р N001034/01 от 2004-12-20
Аскорутин - инструкция по медицинскому применению - РУ № ЛС-000502 от 2012-05-18
Аскорутин - инструкция по медицинскому применению - РУ № Р N000557/01 от 2007-08-31
Аскорутин - инструкция по медицинскому применению - РУ № Р N001034/01 от 2006-12-29
Аскорутин - инструкция по медицинскому применению - РУ № ЛСР-007344/09 от 2009-09-16
Аскорутин - инструкция по медицинскому применению - РУ № Р N000705/01 от 2016-01-22

Nature and contents of container

Pills 1 table.
ascorbic acid 50 mg
routine 50 mg
excipients: sugar, potato starch, calcium stearate, talc  

in polymer cans of 30 or 50 pcs., in a pack of cardboard 1 bank, or in a contour cell package of 10 pcs., in a pack of cardboard 1 or 5 packages.

Nosological classification (ICD-10)

  • D69. 0 Allergic purpura
  • D69. 9 Hemorrhagic condition, unspecified
  • E54 Ascorbic acid [vitamin C] deficiency]
  • E56. 8 Deficiency of other vitamins
  • H35. 6 Retinal hemorrhage
  • I78. 9 Capillary disease, unspecified
  • Y44. 2 Adverse reactions in the therapeutic use of anticoagulants
  • Y45. 1 Adverse reactions during therapeutic use of salicylates

Dosage (Posology) and method of administration

Inside, after the meal. Adults — 1 table. 2-3 times a day. The course of treatment depends on the severity and nature of the disease.

ATC - Anatomical and therapeutic chemical classification

C05CA51 Rutoside in combination with other drugs